CoronaryAtlas logo
CoronaryAtlas
triglyceride
Pathway / Lipid retention & oxidation

triglyceride

metabolite

Elevated triglycerides reflect accumulation of atherogenic lipoproteins in the intima, driving oxidative lipid modification and atherosclerotic plaque formation.

Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationaleComponent of atherogenic lipid profile; triglyceride-rich lipoprotein retains in subendothelium.
Druggability
Not assessed (no mapped human gene target).

Type I vs non-Type I discrimination

ScoresIndeterminate
R — rupture / Type-I
67
C — non-Type-I
44
A — assay feasibility
42
E — evidence strength
72
T1DI (composite)
19
Specificity differential (R−C)+22.3
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
2sepsis / systemic inflammationmag 2
2anemia / acute blood lossn/a
2hypovolemia / dehydrationmag 2
2tachyarrhythmiamag 1
2hypoxemia / respiratory failuren/a
2hypertensive emergencymag 2
2high-demand / peri-operative stressmag 1
3sudden cardiac deathmag 1
4aPCI-related periproceduraln/a
4bstent thrombosismag 1
4cin-stent restenosismag 1
5CABG-relatedmag 1
Coverage: 9/12 axes with evidence
Tier: deep-scored (abstract-extracted) · 16 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research

Literature evidence(7)

Clinical trials(1)